Rici Healthcare Holdings Limited logo

Rici Healthcare Holdings Limited

1526.HK

HKSEHealthcareMedical - Care Facilities

Latest quote

HK$0.815

−HK$0.035 · -4.12%

Aug 24, 3:12 PM HKTData delayed

1526.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical examination centers. By the close of 2021, specifically December 31st, the company's network included 68 medical examination centers. Beyond these core activities, Rici Healthcare also offers health advisory services, nursing care, diagnostic testing, and leasing arrangements. The firm was established in 2000 and has its principal corporate office located in Shanghai, China.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
CN
CEO
Fang Yi Xin
Listed since
Oct 6, 2016
Employees
8,523

Market position

Day range

Current HK$0.815

52-week range

Current HK$0.815

Open
HK$0.85
Previous close
HK$0.85
Volume
42K
0.11× average
Average volume
392.89K
Average daily volume
Market cap
1.29B HKD
Beta
0.68
Market reference 1
50-day average
HK$1.013
-19.55% below average
200-day average
HK$0.9296
-12.33% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.46B CNY
EV / EBITDA
2.78×
Earnings yield
19.20%
Free cash flow yield
35.10%

Profitability & efficiency

Return on equity
18.65%
Return on assets
6.29%
Return on invested capital
12.01%

Financial health

Current ratio
0.98×
Altman Z-score
2.26
Piotroski F-score
7 of 9

Earnings

Latest EPS result
0.14

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.30.180.06-0.06Q2 '21Q4 '21Q3 '22Q2 '23Q3 '23Q1 '24Q3 '24Q1 '25
Q2 2021, reported Jun 30, 2021: actual 0.008, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual 0.261, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Aug 30, 2022: actual -0.017, estimate —, surprise —, Comparison unavailable. Q2 2023, reported Apr 1, 2023: actual 0.225, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 30, 2023: actual 0.084, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual 0.167, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 29, 2024: actual 0.057, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual 0.142, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.97B1.6B1.23B865.92MQ2 '21No estimateQ4 '21No estimateQ3 '22MissQ2 '23BeatQ3 '23MissQ1 '24BeatQ3 '24No estimateQ1 '25No estimate
Q2 2021, reported Jun 30, 2021: actual 1.2B HKD, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual 1.69B HKD, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Aug 30, 2022: actual 941.84M HKD, estimate 1.51B HKD, surprise -37.78%, Miss. Q2 2023, reported Apr 1, 2023: actual 1.79B HKD, estimate 1.51B HKD, surprise +18.16%, Beat. Q3 2023, reported Aug 30, 2023: actual 1.39B HKD, estimate 1.51B HKD, surprise -8.24%, Miss. Q1 2024, reported Mar 28, 2024: actual 1.89B HKD, estimate 1.51B HKD, surprise +24.91%, Beat. Q3 2024, reported Aug 29, 2024: actual 1.32B HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual 1.8B HKD, estimate —, surprise —, Comparison unavailable.

1526.HK peers

Continue in GoAI

Research 1526.HK

research.disclaimer